| The Wall Street Journal Western Edition 1999 Rochelle Sharpe |
| Title | Subject | Authors |
|---|
| FDA vows top priority for food-safety items.(Abstract) | Business, general | Rochelle Sharpe |
| Glaxo Wellcome's new flu drug fails to clear FDA panel on trial results.(Abstract) | Business, general | Rochelle Sharpe |
| J&J's cholesterol-lowering spread to be sold as food, not supplement.(Johnson & Johnson)(Abstract) | Business, general | Ernest Beck, Rochelle Sharpe |
| Judge deals blow to FDA with ruling that Cholestin is a dietary supplement.(Pharmanex Inc. manufactures the cholesterol-reducing product)(Abstract) | Business, general | Rochelle Sharpe |
| Monsanto drug could ignite marketing war; drug approved by FDA to treat arthritis pain may not cause ulcers.(Abstract) | Business, general | Thomas M. Burton, Rochelle Sharpe |
| USDA to allow meatpackers, processors to sterilize products with radiation.(Abstract) | Business, general | Bruce Ingersoll, Rochelle Sharpe |
| Warner-Lambert's Rezulin sales could suffer.(sales of drug for diabetes could suffer )(Abstract) | Business, general | Robert Langreth, Rochelle Sharpe |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
